Statistics for Merck &Inc (id:8477 MRK)
Valuation metrics
Market cap
249.72B
Enterprise value
275.35B
Trailing P/E (ttm)
20.65
Forward P/E
10.50
PEG ratio
10.50
Price/Sales (ttm)
3.95
Price/Book (mrq)
5.62
Enterprise Value/Revenue
4.36
Enterprise Value/EBITDA
12.01
Overview
Shares outstanding
2.53B
Float
2.53B
Shares short
32.79M
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
12.19M
Average volume (90 days)
Price summary
52-Week low
94.48
52-Week high
134.63
52-Week change
-9.77%
Beta
3.00
50-Day moving average
102.59
200-Day moving average
118.05
Dividends and splits
Forward annual dividend rate
3.24
Forward annual dividend yield
5.00
Trailing annual dividend rate
3.04%
Trailing annual dividend yield
5.00
5-Year annual dividend yield
2.90
Payout ratio
3.00
Dividend date
January 8, 2025
Ex-dividend date
December 16, 2024
Last split factor
2:1
Last split date
June 3, 2021
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
19.23%
Operating margin
26.20%
Operational effectiveness
Return on assets
10.53%
Return on equity
28.33%
Income statement
Revenue (ttm)
24.93
Revenue per share (ttm)
24.93
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
43.99B
EBITDA
7.54B
Net income to common (ttm)
12.15B
Diluted EPS (ttm)
4.78
Quarterly earnings growth (yoy)
-33.50%
Balance sheet
Total cash (mrq)
14.59B
Total cash per share (mrq)
5.77
Total debt (mrq)
38.13B
Total Debt/Equity (mrq)
85.57
Current ratio (mrq)
136.40%
Book value per share (mrq)
17.58
Cash flow
Cash flow statement
18.26B
Levered free cash flow (LFCF)
14.02B